NEWARK, Del, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The coagulation analyzer market is poised for significant growth, with its size expected to increase from US$ 4.8 billion in 2024 to US$ 9.2 billion by 2034. Over the next decade, a moderate 6.6% CAGR in the adoption of coagulation analyzers is projected to drive this expansion.
Blood problems and heart ailments have become noticeably prevalent in the last several years. The demand for coagulation analyzers has increased since people dealing with these illnesses frequently require continuous surveillance and diagnostic procedures.
An increase in the elderly population indicates a change in the global demographic landscape. The demand for advanced healthcare tools like coagulation analyzers has increased because elderly people are intrinsically more vulnerable to heart conditions. This demographic trend significantly accelerates the coagulation analyzer market's growth trajectory.
Request a Sample of this Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-8884
Infrastructure development in the healthcare industry is taking place at a rapid pace. Innovations in laboratories, diagnostic centers, and medical facilities are all part of this progression. The incorporation of contemporary healthcare technology into these renovated infrastructures drives the market expansion as a whole, as the coagulation analyzer is an important medical tool. Therefore, coagulation analyzer market expansion is primarily reliant on the growth of healthcare facilities and technology advancement working together.
“Given ongoing technological advancements, the coagulation analyzer industry is set to display promising future opportunities. Fully automated systems, seamless integration with pre- and post-analytical platforms, and full compatibility with Laboratory Information Systems (LIS) are driving user demand. The expansion of interference detecting systems and ready-to-use stability reagents further enhance its promising outlook.” according to Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Key Takeaways from the Coagulation Analyzer Market
- Between 2019 and 2023, the coagulation analyzer industry recorded a CAGR of 9.8%.
- The coagulation analyzer industry in the United States is estimated to witness moderate growth with a projected 6.7% CAGR from 2024 to 2034, driven by an increasing awareness of the importance of early detection and monitoring of coagulation disorders.
- China's coagulation analyzer industry is projected to follow closely with an estimated 6.9% CAGR through 2034, attributed to the country's increasing focus on elevating its healthcare infrastructure.
- The coagulation analyzer market in the United Kingdom is likely to show a 7.7% CAGR between 2024 and 2034, influenced by the growing awareness and emphasis on preventive healthcare measures.
- Japan's coagulation analyzer industry is projected to develop at 7.8% CAGR through 2034, propelled by the country’s unwavering dedication to technological innovation in the healthcare sector.
- The South Korea coagulation analyzer industry is likely to exhibit an 8.8% CAGR from 2024 to 2034, impacted by the rising burden of chronic diseases and a steadily aging population.
Buy Now Report Here: https://www.futuremarketinsights.com/checkout/8884
Key Players and Strategies for Success in the Coagulation Analyzer Market
Here are some key strategies that players in the coagulation analyzer industry employ for success:
- Focus on developing cutting-edge technologies to stay ahead
- Build strong collaborations with healthcare institutions to enhance product development
- Adhere to strict regulatory standards to ensure product quality and market acceptance
- Implement robust quality control measures to guarantee the accuracy and reliability
- Embrace eco-friendly practices in manufacturing and packaging to match sustainability goals
The Top Key Market Players Offering Coagulation Analyzer
- Abbott Laboratories
- Danaher Corp.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
Recent Developments in the Coagulation Analyzer Market
- Sysmex Corporation confirmed the release of several fresh hemostasis products in July 2020, including the Automated Blood Coagulation Analyzers CN-6500/CN-3500. One of the measurement units included with the latest Sysmex products uses the chemiluminescence enzyme immunoassay approach (CLEIA).
- Two modern automated blood coagulation analyzers, the CN-3500 and CN-6500, were introduced by Sysmex Europe in July 2021 in a few EMEA nations. Large and medium-sized hospitals, commercial labs, and other establishments are among the targets.
Request a Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-8884
Key Segments in the Coagulation Analyzer Market Report
By Product Type:
- Semi-automated
- Automated
- Manual
- Others
By Test Type:
- Prothrombin Time Testing
- Fibrinogen Testing
- Activated Partial Thromboplastin Time Testing
- D-dimer Testing
- Platelet Function Testing
- Anti-factor Xa Testing
- Others
By Technology:
- Optical Technology
- Mechanical Technology
- Electrochemical Technology
- Others
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa (MEA)
Have a Look at the Related Report from the Coagulation Analyzer Market:
Coagulation Analysers Market is expected to enjoy a valuation of US$ 1.1 Billion in 2022, and further expand at a CAGR of 6.8% between 2022 and 2032 to reach a valuation of ~US$ 2.1 Billion by 2032.
Coagulation Disorders Market is a condition that affects the way blood normally clots. This clotting process is generally known as coagulation. For the blood to clot, the body requires certain proteins called clotting factors and blood cells called platelets.
Blood Coagulation Analyzers Market size is likely to be valued at US$ 3,038.9 million by 2023 and is expected to reach US$ 5,680.7 million by 2033.
Coagulation Markers Market size is projected to be worth US$ 1.21 billion in 2023. The market is likely to surpass US$ 2.22 billion by 2033 at a CAGR of 6.3% during the forecast period.
Special Coagulation Tests Market are performed to measure the blood’s ability to clot and the time taken in it. The special coagulation tests are prescribed by the doctor in case of clotting disorders.
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
